Roche Holding Ltd (OP: RHHVF )
332.65
+0.89
(+0.27%)
Streaming Delayed Price
Updated: 2:16 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Roche Holding Ltd
![](https://cdn.benzinga.com/files/images/story/2023/02/23/bpmc_blueprint_medicines_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/10/roche_storytemplate_history_1991_02.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/07/roche.png?width=1200&height=800&fit=crop)
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
February 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/02/roche.png?width=1200&height=800&fit=crop)
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
February 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/19/roche_storytemplate_history_1991_02.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/12/roche.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/roche.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/23/roche.png?width=1200&height=800&fit=crop)
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/22/roche.png?width=1200&height=800&fit=crop)
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/12/roche_0.png?width=1200&height=800&fit=crop)
Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/12/roche.png?width=1200&height=800&fit=crop)
After 16 Years, Roche's Pharma Division Head Decides To Step Down
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/07/repl_logo_light__3959434ad89734e0e649ecfca0aee813.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/16/covid-19_corona-5174671_1920__image_by_gerd_altmann_from_pixabay_.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/monkeypox-photo_jernej_furman_from_flickr..jpg?width=1200&height=800&fit=crop)
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
November 16, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/15/roche.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/15/aapharma_13.png?width=1200&height=800&fit=crop)
Roche Inks Second Drug Discovery Deal With Jnana Therapeutics
November 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/14/aapharma_19.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/mor_logo_light__919dcbcf9799d34a73e1fa8f2921588e.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/aapharma.png?width=1200&height=800&fit=crop)
Roche Posts Lower Quarterly Sales As Demand For COVID Products Slide
October 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/12/aapharma_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/12/swab_test-photo_by_mufid_majnun_on_unsplash_.jpg?width=1200&height=800&fit=crop)
Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests
October 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/03/aapharma.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/27/aapharma_17.png?width=1200&height=800&fit=crop)
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/23/swab_test-photo_by_mufid_majnun_on_unsplash_.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/aapharma_5.png?width=1200&height=800&fit=crop)
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/16/who_and_roche_covid-19_miguel_a._padrinan_by_pexels_and_wikipedia.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/29/swab_test-photo_by_mufid_majnun_on_unsplash_.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/25/aapharma_16.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/18/aapharma_10.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/16/aapharma_17.png?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.